JJ

Jenil Jagdishbhai Bhalala

Active Director Director DIN 11325458
DIN 11325458 First appointment Oct 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jenil Jagdishbhai Bhalala

Data last updated:

Jenil Jagdishbhai Bhalala is a Director at Nutriberg Pharma India Private Limited (since 2025). The company operates in Paper.

DIN 11325458
Primary Designation Director
Industry Paper
First Appointment 15 Oct 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Oct 2025Active

Directorship timeline

Open interactive timeline →
Nutriberg Pharma India Private Limited
Premium access

Shareholding and investment profile for Jenil Jagdishbhai Bhalala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jenil Jagdishbhai Bhalala

Jenil Jagdishbhai Bhalala currently holds 1 directorship: Nutriberg Pharma India Private Limited (Director, since 15 Oct 2025).

Jenil Jagdishbhai Bhalala was first appointed on 15 Oct 2025 as Director at Nutriberg Pharma India Private Limited.

The current boards of Jenil Jagdishbhai Bhalala's companies include Chirag Mansukhbhai Chikhaliya (Nutriberg Pharma India Private Limited), Jagdishkumar Savjibhai Bhalala (Nutriberg Pharma India Private Limited), Viral Mansukhbhai Chikhaliya (Nutriberg Pharma India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available